Bank of Montreal
GYRE icon

Bank of Montreal’s Gyre Therapeutics GYRE Stock Holding History

Bank of Montreal’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,835
Closed -$962K – 3641
2021
Q3 		$962K Sell
26,835
-1,485
-5% -$48.9K ﹤0.01% 2522
2021
Q2 		$971K Buy
28,320
+7,572
+36% +$260K ﹤0.01% 2502
2021
Q1 		$805K Buy
20,748
+2,067
+11% +$94.5K ﹤0.01% 2356
2020
Q4 		$904K Buy
18,681
+18,545
+13,636% +$803K ﹤0.01% 2311
2020
Q3 		$5K Sell
136
-89
-40% -$3.48K ﹤0.01% 4422
2020
Q2 		$10K Buy
+225
New +$10.6K ﹤0.01% 4167
2019
Q3 		– Sell
-2
Closed – – 4822
2019
Q2 		$0 Buy
+2
New +$125 ﹤0.01% 4951
2019
Q1 		– Sell
-22
Closed -$1K – 4496
2018
Q4 		$1K Buy
22
+11
+100% +$811 ﹤0.01% 4531
2018
Q3 		$1K Hold
11
– – ﹤0.01% 4536
2018
Q2 		$1K Buy
+11
New +$1.93K ﹤0.01% 4532
2017
Q2 		– Sell
-1,128
Closed -$80K – 4202
2017
Q1 		$80K Buy
+1,128
New +$65.9K ﹤0.01% 2908
2014
Q3 		– Sell
-1
Closed -$3K – 4176
2014
Q2 		$3K Buy
+1
New +$3.26K ﹤0.01% 4368

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Bank of Montreal's GYRE Position: Q4 2021 in Review

Bank of Montreal sold out of Gyre Therapeutics (GYRE) in Q4 2021, closing a stake of 26,835 shares — an estimated $962K sold.

Bank of Montreal first reported a position in GYRE in Q2 2014 and held it in 12 quarters. The position peaked at $971K in Q2 2021. 51 funds tracked by Wall St. Rank hold GYRE as of Q4 2021.

  • Bank of Montreal reported no remaining Gyre Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 26,835 Gyre Therapeutics shares in Q4 2021, an estimated $962K.
  • Bank of Montreal first reported a position in Gyre Therapeutics in Q2 2014 and held it in 12 quarters.
  • Bank of Montreal's Gyre Therapeutics position peaked at $971K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.